Search Bar & Filters
Found 17 Actively Recruiting clinical trials
Actively Recruiting
Healthy Volunteer
Researchers are studying the challenges and support related to breast cancer diagnosis in Tanzania. This observational study focuses on understanding barriers to hormone receptor testing in breast cancer patients and the healthcare system. The goal is to improve the diagnosis process by gathering insights from survivors, patient advocates, and key healthcare personnel. The study involves behavioral interventions such as semi-structured focus group discussions and the use of a survey tool called Organizational Readiness for Implementing Change ORIC. The focus groups explore contextual factors, barriers, and facilitators to implementing changes, while the ORIC tool assesses how prepared organizations are for change using participant ratings on a 5-point scale. Participants include breast cancer survivors, patient advocates, and healthcare workers involved in breast cancer care. Participants will engage in focus groups and complete readiness assessments. Data collection involves interviews and chart reviews to identify diagnosis barriers over one year. The research team evaluates organizational preparedness and collects participant feedback through discussions. The study is expected to continue until April 2027, with no direct treatment involved, focusing on improving breast cancer diagnosis support and processes.
Actively Recruiting
Researchers are developing and testing a culturally tailored yoga therapy program for cancer patients undergoing hematopoietic stem cell transplantation HSCT in India, Tanzania, and the United States. This program aims to address cultural norms and provide psychosocial support through yoga to improve patient well-being during and after transplant. The study focuses on creating a sensitive, patient-centered approach by involving patients from each center in interviews and program design. Participants will engage in gentle yoga movements, breathing exercises, relaxation techniques, and meditation tailored to their individual needs. The program includes up to 12 yoga sessions, delivered three times per week starting two weeks before the transplant and continuing throughout the first 30 days of hospitalization. Sessions may be conducted in person, via telehealth, or a combination of both. Participants will also complete questionnaires about symptoms, anxiety, depression, quality of life, and treatment expectations, along with exit interviews. During the study, researchers will monitor adherence to the yoga sessions and completion of follow-up assessments at two months post-transplant. Participants will be assessed using the Patient Health Questionnaire-8 PHQ-8 over about one year. The study includes interviews and questionnaires to evaluate the programs acceptability and impact. The total involvement includes the yoga program during hospitalization and follow-up assessments to understand patient outcomes and feasibility of the intervention.
Actively Recruiting
This observational study evaluates the effects of a nurse-led stroke transitional care program on stroke survivors, their caregivers, and healthcare providers. The goal is to see if this program improves discharge preparedness, disease self-management, and quality of life for stroke survivors. Participants are stroke survivors and their caregivers who are already receiving this program as part of their medical care. The research is sponsored by Shandong University and focuses on stroke patients in Tanzania. Participants receive usual care plus the nurse-led stroke transitional care, which includes face-to-face and telephone sessions. During hospitalization, two nurse champions conduct five face-to-face sessions, including individual and group sessions with patients and caregivers. After discharge, two nurse researchers provide seven follow-up phone call sessions over three months. Face-to-face sessions last 40-60 minutes, and phone calls last 20-30 minutes. Stroke survivors and their caregivers are followed for six months to assess the quality of transitional care and various clinical outcomes. Researchers measure self-efficacy, quality of life, discharge preparedness, resilience, depression, anxiety, care satisfaction, mortality, readmission rates, and length of hospital stay. These assessments occur at specific times from admission through six months after discharge to monitor the programs impact and participant well-being.
Actively Recruiting
Healthy Volunteer
Researchers are evaluating the Familia Imara program, a group-based, couples-focused parenting intervention aimed at reducing intimate partner violence IPV, harsh discipline, and improving child development and nutrition in the Mara and Geita regions of Tanzania. This cluster-randomized controlled trial will assess the programs effectiveness, implementation, and scalability in community settings, focusing on families with children under two years old. The study is conducted in two sequential cohorts to compare traditional delivery with government-led scale-up. The Familia Imara program is delivered by trained community health workers CHWs who facilitate joint couples sessions and separate peer group sessions for mothers and fathers. Sessions last about two hours and occur twice monthly over approximately 10 months. Cohort 1 compares intervention villages receiving the program to control villages on a waitlist. In Cohort 2, intervention villages receive the program under government-led delivery, while control villages transition to receive the intervention with combined support from partners and government supervisors. Participants include couples with a child under two years living together who consent to participate. Data collection involves surveys at baseline, 11 months, and 22 months to measure outcomes such as maternal IPV victimization, child dietary diversity, harsh disciplinary practices, and early child development using the Caregiver Reported Early Development Instrument. Secondary outcomes include attitudes toward IPV, parenting, child nutrition knowledge, and gender norms. The study also assesses program delivery models and supports policy development for family violence prevention and child development.
Actively Recruiting
Evaluating Local Gentamicin Injection Versus Saline for Infection Prevention in Open Tibia Fractures
Open tibia fractures, which expose the shinbone through the skin, often lead to infections and complications that can cause long-term disability or amputation. Researchers are evaluating the effect of applying the antibiotic gentamicin directly to these open wounds to see if it reduces infection risk. This is the first randomized clinical trial to test this local antibiotic approach in such fractures, with potential to improve care worldwide, especially in low-income countries. Participants will receive either gentamicin liquid or a saline solution injected directly into the fracture wound during surgery. Both treatments involve injecting 5 mL of solution at the fracture site using a small needle. The gentamicin dose is 80 mg diluted in saline. The study compares infection rates between those receiving gentamicin and those receiving saline, with all other care being standard. During the 12-month participation, patients will be monitored for fracture-related infections, bone healing, need for additional surgery, and quality of life using questionnaires and imaging assessments. Researchers will track healing progress and any complications over this period. The study is randomized and blinded to keep treatment assignment unbiased, and participation includes regular follow-up visits to measure health outcomes and safety.
Actively Recruiting
Researchers are investigating the nutritional status and its impact on treatment outcomes in children and adolescents newly diagnosed with B- or T-cell acute lymphoblastic leukemia or mixed phenotype acute leukemia. This observational study aims to create a biobank of clinical data and biological specimens from participants aged 3 to 18 years, enhancing understanding of cancer progression, prognosis, treatment toxicities, survivorship, and late effects, especially in low and middle income countries. Participants will have biological samples such as stool and blood collected at key treatment milestones including diagnosis, end of induction, beginning of maintenance, end of treatment, and one year post-treatment. Alongside, data on socioeconomic status, food security, diet, physical activity, and nutritional measurements like height, weight, and arm size will be gathered throughout the treatment period and follow-up. During the study, researchers will collect demographic, lifestyle, clinical, and nutritional information at various timepoints to accompany the biorepository. The main outcomes include establishing a multinational biobank and compiling comprehensive data on treatment-related toxicities, survival, and nutrition over seven years. Participant involvement includes multiple assessments and sample collections over the treatment course and one year after treatment ends.
Actively Recruiting
Healthy Volunteer
Researchers are evaluating the implementation and impact of a distribution program for low dead-space syringes and needles LDSSN in multiple low- and middle-income countries including Armenia, Georgia, Tanzania, Egypt, Nigeria, Vietnam, India, Ukraine, and South Africa. The study aims to identify best practices for LDSSN distribution to improve acceptance and maintain high usage rates among people who inject drugs PWID. This observational research also explores community preferences and barriers related to LDSSN access and usage. The study involves three phases Phase 1 includes focus group discussions FGDs with PWID to present and discuss various LDSSN products and gather feedback to inform selection. Phase 2 consists of a 6-week pilot where participants can access selected LDSSN products alongside usual needle and syringe program NSP services, followed by a second round of FGDs to reflect on experiences. In Phase 3, a selection of LDSSN products will be made available at NSP sites, while routine programmatic data and a cohort study with 240 participants per country 480 in Nigeria collect information on LDSSN uptake, HIV and HCV testing, and behavioral surveys over 18 months. Participants will be involved in surveys, HIV and HCV antibody testing at baseline, 6, 12, and 18 months, and ongoing access to usual services and LDSSN products. Data collection also includes routine program data on needle use and focus groups to assess acceptability and impact. Key informant interviews will evaluate feasibility and effectiveness, while mathematical modeling will estimate public health impact and cost-effectiveness of scaling up LDSSN distribution among PWID. The primary outcome measures the effectiveness of the community-informed LDSSN distribution program on increasing uptake over 18 months.
Actively Recruiting
Researchers are evaluating large language models LLMs as clinical decision support tools in healthcare settings of low and middle income countries. These settings often face challenges such as time pressure, limited diagnostic resources, and inconsistent access to current clinical guidelines. This observational study, part of the MOOVE project, aims to rigorously assess LLMs performance and safety compared to human clinical care in real-world acute condition cases. The study is non-interventional and conducted during routine outpatient care in participating facilities. Patient clinical and demographic data collected during visits are used to retrospectively prompt the LLMs without affecting patient treatment. The LLM outputs and human care plans are reviewed by independent clinical experts. Implementation feasibility is also assessed by gathering clinician feedback on the LLM interface, output clarity, relevance, safety perceptions, and alignment with clinical workflows and guidelines. Participants are followed up at 7 and 28 days after enrollment to collect clinical outcomes for evaluating LLM safety and performance. The study also monitors clinician experience and organizational readiness for future LLM implementation from week 4 until study completion. Outcome measures include performance scores at day 0 and safety thresholds at days 7 and 28, alongside ongoing implementation feasibility research. The total study duration extends through 2026.
Actively Recruiting
Healthy Volunteer
Researchers are investigating the impact of multiple micronutrient supplements MMS with varying iron doses on preventing moderate or severe anemia in pregnant women. This Phase 3 randomized controlled trial focuses on comparing MMS containing 60 mg and 45 mg of iron against the standard MMS containing 30 mg of iron, aiming to provide guidance for countries like Tanzania on the most suitable iron dose during pregnancy. Participants are randomly assigned to one of three groups receiving MMS with either 30 mg, 45 mg, or 60 mg of elemental iron daily from the time of randomization until delivery. All groups receive the standard UNIMMAP formulation with 15 micronutrients, differing only in the iron content. The supplements are taken orally once a day as part of routine antenatal care. During the study, pregnant women will be monitored through the third trimester and up to 6 weeks postpartum. Researchers will assess anemia levels, hemoglobin concentration, iron status, pregnancy complications, maternal symptoms, birth outcomes, and infant health measures. Study visits include evaluations of blood tests, maternal and infant health, and questionnaires on symptoms such as fatigue and depression. The total participation duration covers pregnancy through 6 weeks after delivery.
Actively Recruiting
Researchers are studying the management of drug resistance in people living with HIV who are on dolutegravir DTG-based antiretroviral therapy but experience treatment failure due to drug-resistant mutations. This phase 3b randomized clinical trial aims to compare the effectiveness and safety of continuing DTG versus switching to ritonavir-boosted darunavir DRVr in patients with HIV-1 RNA levels above 200 copiesmL and at least one major DTG-associated drug resistance mutation. The study addresses gaps in current treatment strategies across several countries. Participants will be randomly assigned to one of two groups one will continue their existing DTG-based ART regimen, and the other will switch to a DRVr-based ART regimen. The dosing will be based on weight, and the study will take place over 12 months at multiple sites in Kenya, Mozambique, Tanzania, and Lesotho. The primary measure is the proportion of participants achieving viral suppression with HIV-1 RNA below 200 copiesmL at 6 months. During the trial, participants will have regular monitoring of their viral load and drug resistance mutations, along with assessments of treatment adherence, safety, and patient satisfaction. Additional outcomes include viral suppression rates at 12 months, incidence of adverse events, and changes in CD4 counts. The study includes children aged 3 years and older and plans to enroll 392 participants. Follow-up and data collection will support understanding optimal treatment management for this population.
1-10 of 17
1